Tag: Lilly

Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It’s Not a Stock Split)

Eli Lilly raises outlook on bumper sales of diabetes and weight loss drugs

Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation

Eli Lilly lifts guidance after sales of Mounjaro and Zepbound drugs soar

Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank

Novo Nordisk and Eli Lilly May Finally Have Some Real Competition

Why Eli Lilly Stock Flopped on Friday

Better Blockbuster-Drug Stock: Novo Nordisk vs. Eli Lilly

Why Novo Nordisk and Eli Lilly Stocks Slipped Today

Where Will Eli Lilly Be in 5 Years?